Sumeet Seth
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$7.9MFederal grants as PI10 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
10 awards · $7.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 12, 2022 | NIH | SBIR Phase II Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease | $98K | EVON MEDICS LLC |
| Jun 2, 2022 | NIH | SBIR Phase II Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD) | $50K | EVON MEDICS LLC |
| May 26, 2022 | NIH | SBIR Phase II Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD) | $1.2M | EVON MEDICS LLC |
| Aug 16, 2021 | NIH | SBIR Phase II Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder | $859K | EVON MEDICS LLC |
| May 1, 2021 | NIH | SBIR Phase II Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease | $2.6M | EVON MEDICS LLC |
| Apr 29, 2021 | NIH | SBIR Phase II Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Early Alzheimer's Disease (AD) | $1.2M | EVON MEDICS LLC |
| Sep 23, 2020 | NIH | SBIR Phase II Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder | $821K | EVON MEDICS LLC |
| Jun 20, 2019 | NIH | SBIR Phase I Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD) | $225K | EVON MEDICS LLC |
| Sep 30, 2018 | NIH | SBIR Phase I Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD) | $450K | EVON MEDICS LLC |
| Sep 17, 2018 | NIH | SBIR Phase I Development and Evaluation of Computerized Olfactory Training Program (COT) for Cognitive Decline in Preclinical and Early Alzheimer's Disease (AD) | $225K | EVON MEDICS LLC |
Peer ranks
Federal funding#120
Awards as PI#141
Patents#505
Companies
- EVON MEDICS LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.